Barclays downgraded Aptiv from Overweight to Equal Weight and set a new price target of $55.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/4/2025 | Buy → Neutral | Guggenheim | |
| 4/15/2025 | $55.00 | Overweight → Equal Weight | Barclays |
| 4/10/2025 | $91.00 → $58.00 | Buy → Neutral | UBS |
| 3/7/2025 | $90.00 | Buy | TD Cowen |
| 2/7/2025 | $78.00 | Hold → Buy | Deutsche Bank |
| 2/4/2025 | $63.00 → $77.00 | Hold → Buy | HSBC Securities |
| 2/3/2025 | Outperform → Mkt Perform | Raymond James | |
| 1/27/2025 | $75.00 → $82.00 | Neutral → Outperform | Robert W. Baird |